SummaryAutism affects about 1 in 36 children in the U.S., according to the CDC. While the exact cause remains unclear, experts agree it’s a complex interplay of genetics and environment—not vaccines.
SummaryCapivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking an abnormal protein—a part of the cancer cell’s signaling system—that tells the cells to multiply. By disrupting this signal, capivasertib slows or halts the progression of the disease.
End of Article
NEXT ARTICLE
Against Experts' Concerns, HHS Releases A New Autism Study
SummaryAfter RFK Jr.'s announcement to carry out a study to find causes for autism, HHS has not released any detailed plans for the study, leaving many questions about its direction, scientific credibility, and impact.